Skip to main content
Lexaria Bioscience Corp. logo

Lexaria Bioscience Corp. — Investor Relations & Filings

Ticker · LEXX ISIN · US52886N4060 US Professional, scientific and technical activities
Open in API
Filings indexed 1,010 across all filing types
Latest filing 2010-09-13 Regulatory Filings
Country US United States of America
Listing US LEXX

About Lexaria Bioscience Corp.

https://www.lexariabioscience.com/

Lexaria Bioscience Corp. is a biotechnology company focused on the development and commercialization of its patented drug delivery platform, DehydraTECH™. This technology is designed to improve the way active pharmaceutical ingredients (APIs) enter the bloodstream through oral administration. DehydraTECH™ enhances the bioavailability of APIs, which can enable faster absorption, increased efficacy, and the potential for reduced drug dosages. The company operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with numerous patents granted globally for its platform technology.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2010
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes details about entering into material definitive agreements, creation of financial obligations, and assignment agreements involving company directors and officers. It also mentions a demand loan agreement with a related party. The document does not contain comprehensive financial statements or detailed financial performance data typical of annual or quarterly reports. It is primarily an announcement of specific corporate events and agreements. Therefore, it fits the category of a Regulatory Filing (RNS), which is a general category for miscellaneous filings that do not fit other specific categories.
2010-09-13 English
PRIMARY DOCUMENT
Director's Dealing
2010-09-09 English
PRIMARY DOCUMENT
Director's Dealing
2010-09-08 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text mentions a press release about the results of a new oil well drilled, which is a specific event disclosure. The document is short (1965 characters) and primarily serves as a notification of this event rather than a detailed financial report or other specific filing type. It does not contain financial statements or detailed management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2010-09-07 English
FORM 10-Q
Interim / Quarterly Report 9M 2010
2010-09-04 English
PRIMARY DOCUMENT
Director's Dealing
2010-08-31 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.